Charcot on Parkinson's disease
Identifieur interne : 003477 ( Istex/Corpus ); précédent : 003476; suivant : 003478Charcot on Parkinson's disease
Auteurs : GoetzSource :
- Movement Disorders [ 0885-3185 ] ; 1986.
English descriptors
Abstract
Charcot saluted Parkinson for his early observations, but condemned his use of the term “paralysis agitans.” He emphasized that patients were neither dramatically weak nor were they necessarily plagued with tremor. Charcot suggested the name “Parkinson's disease,” although he could not resist the comment in his amphitheater lecture series at the Salpětrièe that French physicians (unnamed) had probably described the disorder before 1817. Tremor, rigidity, postural instability, and bradykinesia were all recognized by Charcot. He classified the disorder as a “névrose,” meaning a neurologic disorder without a known pathologic lesion, and found little benefit from therapies available at the time, including belladonna and ergot products.
Url:
DOI: 10.1002/mds.870010104
Links to Exploration step
ISTEX:FA1981D5F032509116396655B1E790B9F6F6511FLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Charcot on Parkinson's disease</title><author><name sortKey="Goetz" sort="Goetz" uniqKey="Goetz" last="Goetz">Goetz</name><affiliation><mods:affiliation>Department of Neurological Sciences, Rush–Presbyterian–St. Lukes Medical Center, Chicago, Illinois, U.S.A.</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:FA1981D5F032509116396655B1E790B9F6F6511F</idno><date when="1986" year="1986">1986</date><idno type="doi">10.1002/mds.870010104</idno><idno type="url">https://api.istex.fr/document/FA1981D5F032509116396655B1E790B9F6F6511F/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003477</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Charcot on Parkinson's disease</title><author><name sortKey="Goetz" sort="Goetz" uniqKey="Goetz" last="Goetz">Goetz</name><affiliation><mods:affiliation>Department of Neurological Sciences, Rush–Presbyterian–St. Lukes Medical Center, Chicago, Illinois, U.S.A.</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1986">1986</date><biblScope unit="vol">1</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="27">27</biblScope><biblScope unit="page" to="32">32</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">FA1981D5F032509116396655B1E790B9F6F6511F</idno><idno type="DOI">10.1002/mds.870010104</idno><idno type="ArticleID">MDS870010104</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Bradykinesia</term><term>Parkinson's disease</term><term>Postural instability</term><term>Rigidity</term><term>Tremor</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Charcot saluted Parkinson for his early observations, but condemned his use of the term “paralysis agitans.” He emphasized that patients were neither dramatically weak nor were they necessarily plagued with tremor. Charcot suggested the name “Parkinson's disease,” although he could not resist the comment in his amphitheater lecture series at the Salpětrièe that French physicians (unnamed) had probably described the disorder before 1817. Tremor, rigidity, postural instability, and bradykinesia were all recognized by Charcot. He classified the disorder as a “névrose,” meaning a neurologic disorder without a known pathologic lesion, and found little benefit from therapies available at the time, including belladonna and ergot products.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Dr. Goetz</name><affiliations><json:string>Department of Neurological Sciences, Rush–Presbyterian–St. Lukes Medical Center, Chicago, Illinois, U.S.A.</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Bradykinesia</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Postural instability</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Rigidity</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Tremor</value></json:item></subject><language><json:string>eng</json:string></language><abstract>Charcot saluted Parkinson for his early observations, but condemned his use of the term “paralysis agitans.” He emphasized that patients were neither dramatically weak nor were they necessarily plagued with tremor. Charcot suggested the name “Parkinson's disease,” although he could not resist the comment in his amphitheater lecture series at the Salpětrièe that French physicians (unnamed) had probably described the disorder before 1817. Tremor, rigidity, postural instability, and bradykinesia were all recognized by Charcot. He classified the disorder as a “névrose,” meaning a neurologic disorder without a known pathologic lesion, and found little benefit from therapies available at the time, including belladonna and ergot products.</abstract><qualityIndicators><score>3.249</score><pdfVersion>1.3</pdfVersion><pdfPageSize>468 x 720 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>741</abstractCharCount><pdfWordCount>1989</pdfWordCount><pdfCharCount>11840</pdfCharCount><pdfPageCount>6</pdfPageCount><abstractWordCount>105</abstractWordCount></qualityIndicators><title>Charcot on Parkinson's disease</title><genre><json:string>Serial article</json:string></genre><host><volume>1</volume><pages><total>6</total><last>32</last><first>27</first></pages><issn><json:string>0885-3185</json:string></issn><issue>1</issue><subject><json:item><value>Original Article</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>1986</publicationDate><copyrightDate>1986</copyrightDate><doi><json:string>10.1002/mds.870010104</json:string></doi><id>FA1981D5F032509116396655B1E790B9F6F6511F</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/FA1981D5F032509116396655B1E790B9F6F6511F/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/FA1981D5F032509116396655B1E790B9F6F6511F/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/FA1981D5F032509116396655B1E790B9F6F6511F/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Charcot on Parkinson's disease</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>1986</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Charcot on Parkinson's disease</title><author><persName><surname>Goetz</surname><roleName type="degree">Dr.</roleName></persName><note type="correspondence"><p>Correspondence: Department of Neurological Sciences, Rush–Presbyterian–St. Lukes Medical Center, 1725 West Harrison Street, Chicago, IL 60612, U.S.A.</p></note><affiliation>Department of Neurological Sciences, Rush–Presbyterian–St. Lukes Medical Center, Chicago, Illinois, U.S.A.</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1986"></date><biblScope unit="vol">1</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="27">27</biblScope><biblScope unit="page" to="32">32</biblScope></imprint></monogr><idno type="istex">FA1981D5F032509116396655B1E790B9F6F6511F</idno><idno type="DOI">10.1002/mds.870010104</idno><idno type="ArticleID">MDS870010104</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1986</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Charcot saluted Parkinson for his early observations, but condemned his use of the term “paralysis agitans.” He emphasized that patients were neither dramatically weak nor were they necessarily plagued with tremor. Charcot suggested the name “Parkinson's disease,” although he could not resist the comment in his amphitheater lecture series at the Salpětrièe that French physicians (unnamed) had probably described the disorder before 1817. Tremor, rigidity, postural instability, and bradykinesia were all recognized by Charcot. He classified the disorder as a “névrose,” meaning a neurologic disorder without a known pathologic lesion, and found little benefit from therapies available at the time, including belladonna and ergot products.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Bradykinesia</term></item><item><term>Parkinson's disease</term></item><item><term>Postural instability</term></item><item><term>Rigidity</term></item><item><term>Tremor</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Original Article</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1986">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/FA1981D5F032509116396655B1E790B9F6F6511F/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="subtitle">Official Journal of the Movement Disorder Society</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="10"><doi origin="wiley" registered="yes">10.1002/mds.v1:1</doi><numberingGroup><numbering type="journalVolume" number="1">1</numbering><numbering type="journalIssue">1</numbering></numberingGroup><coverDate startDate="1986">1986</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="4" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.870010104</doi><idGroup><id type="unit" value="MDS870010104"></id></idGroup><countGroup><count type="pageTotal" number="6"></count></countGroup><titleGroup><title type="articleCategory">Original Article</title><title type="tocHeading1">Original Articles</title></titleGroup><copyright ownership="thirdParty">Copyright © 1986 Movement Disorder Society</copyright><eventGroup><event type="firstOnline" date="2005-05-23"></event><event type="publishedOnlineFinalForm" date="2005-05-23"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-09"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">27</numbering><numbering type="pageLast">32</numbering></numberingGroup><correspondenceTo>Department of Neurological Sciences, Rush–Presbyterian–St. Lukes Medical Center, 1725 West Harrison Street, Chicago, IL 60612, U.S.A.</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS870010104.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="2"></count><count type="tableTotal" number="0"></count><count type="referenceTotal" number="7"></count></countGroup><titleGroup><title type="main" xml:lang="en">Charcot on Parkinson's disease</title><title type="short" xml:lang="en">CHARCOT ON PARKINSON'S DISEASE</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><honorifics>Dr.</honorifics><givenNames>Christopher G.</givenNames><familyName>Goetz</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>Department of Neurological Sciences, Rush–Presbyterian–St. Lukes Medical Center, Chicago, Illinois, U.S.A.</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Bradykinesia</keyword><keyword xml:id="kwd2">Parkinson's disease</keyword><keyword xml:id="kwd3">Postural instability</keyword><keyword xml:id="kwd4">Rigidity</keyword><keyword xml:id="kwd5">Tremor</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>Charcot saluted Parkinson for his early observations, but condemned his use of the term “paralysis agitans.” He emphasized that patients were neither dramatically weak nor were they necessarily plagued with tremor. Charcot suggested the name “Parkinson's disease,” although he could not resist the comment in his amphitheater lecture series at the Salpětrièe that French physicians (unnamed) had probably described the disorder before 1817. Tremor, rigidity, postural instability, and bradykinesia were all recognized by Charcot. He classified the disorder as a “névrose,” meaning a neurologic disorder without a known pathologic lesion, and found little benefit from therapies available at the time, including belladonna and ergot products.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 4-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Charcot on Parkinson's disease</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>CHARCOT ON PARKINSON'S DISEASE</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Charcot on Parkinson's disease</title></titleInfo><name type="personal"><namePart type="termsOfAddress">Dr.</namePart><namePart type="family">Goetz</namePart><affiliation>Department of Neurological Sciences, Rush–Presbyterian–St. Lukes Medical Center, Chicago, Illinois, U.S.A.</affiliation><description>Correspondence: Department of Neurological Sciences, Rush–Presbyterian–St. Lukes Medical Center, 1725 West Harrison Street, Chicago, IL 60612, U.S.A.</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">article</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">1986</dateIssued><copyrightDate encoding="w3cdtf">1986</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">2</extent><extent unit="references">7</extent></physicalDescription><abstract lang="en">Charcot saluted Parkinson for his early observations, but condemned his use of the term “paralysis agitans.” He emphasized that patients were neither dramatically weak nor were they necessarily plagued with tremor. Charcot suggested the name “Parkinson's disease,” although he could not resist the comment in his amphitheater lecture series at the Salpětrièe that French physicians (unnamed) had probably described the disorder before 1817. Tremor, rigidity, postural instability, and bradykinesia were all recognized by Charcot. He classified the disorder as a “névrose,” meaning a neurologic disorder without a known pathologic lesion, and found little benefit from therapies available at the time, including belladonna and ergot products.</abstract><subject lang="en"><genre>Keywords</genre><topic>Bradykinesia</topic><topic>Parkinson's disease</topic><topic>Postural instability</topic><topic>Rigidity</topic><topic>Tremor</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title><subTitle>Official Journal of the Movement Disorder Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><subject><genre>article category</genre><topic>Original Article</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>1986</date><detail type="volume"><caption>vol.</caption><number>1</number></detail><detail type="issue"><caption>no.</caption><number>1</number></detail><extent unit="pages"><start>27</start><end>32</end><total>6</total></extent></part></relatedItem><identifier type="istex">FA1981D5F032509116396655B1E790B9F6F6511F</identifier><identifier type="DOI">10.1002/mds.870010104</identifier><identifier type="ArticleID">MDS870010104</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 1986 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003477 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 003477 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:FA1981D5F032509116396655B1E790B9F6F6511F
|texte= Charcot on Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |